Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...
Treatment with the investigational next-generation KRAS-G12C inhibitor elisrasib led to clinical benefit in patients with ...
Researchers uncover how mutant lung cells reshape surrounding tissue through signaling loops with fibroblasts and immune ...
A Memorial Sloan Kettering Cancer Center study has found that KRAS-mutated lung cells can trigger fibrotic tissue remodeling long before tumors are detectable. Using advanced molecular mapping, ...
Researchers have found a link between healthier diets containing fruits, vegetables, and whole grains and higher rates of ...
Cancer isn't a static target. Its genetic profile can change. So even with the newer targeted therapies, a patient's care ...
Afatinib almost doubled progression-free survival versus chemotherapy in advanced lung cancer with uncommon EGFR mutations. The treatment effect was consistent across major uncommon mutations, ...
Eligible patients had locally advanced or metastatic NSCLC with prespecific actionable GAs, had progressed after standard treatment and received no more than one previous line of chemotherapy.
Jaymie Knox had never smoked a cigarette. She kickboxed regularly. Still, she got stage 4 lung cancer. And she's not alone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results